FDA Panel Backs Ketamine-Like Drug for Depression

WEDNESDAY, Feb. 13, 2019 -- An expert panel for the U.S. Food and Drug Administration has endorsed a drug for major depressive disorder that is a close relative to ketamine. If approved by the FDA, the new drug known as esketamine would be available...

http://bit.ly/2tl8pmP